Treatment with CSF from ALS patients – but not control CSF – was reported to trigger cytoplasmic TDP-43 mislocalization in spinal motor neurons of hTDP-43 mice, along with increased levels of insoluble TDP-43. Here, TARDBP is linked to amyotrophic lateral sclerosis.